Home  Research & Development |
| |
| Research & Development |
 |
| Wanbury’s R & D is recognized by Department of Scientific & Industrial Research (DSIR), Government of India and its team of dedicated Scientists and Research Doctors are into: |
| |
Process Research : APIs for Regulated Markets / Emerging Markets and Custom Synthesis. |
|
Pharma Research : Development of ANDAs and finished dosages for Regulated Markets. |
| NDDS : Development of Novel platforms for Speciality Generics and IPR. |
| New Drug Combination |
| |
| Wanbury’s current focus is to strengthen its grip on the supply of APIs to customers in regulatory market, specifically in Europe and USA. Wanbury’s chemical R & D department continuously innovates and remains competitive by developing/acquiring ability to sort out simple and effective solutions to practical problems. |
| |
| The strength of R & D comes from highly competitive scientists supported by excellent instrumentation facility, which includes sophisticated instruments like HPLC, FTIR, and GC with head space, and particle size analyzer etc. |
| |
| In a nutshell, the current activities of R & D functions include: |
| Development of new products |
| Impurity profiling of API’s |
| Analytical method development. |
| Process development/improvements to make products competitive & profitable in long run by giving major emphasis to : |
| * Utilization of cheaper raw materials |
| * Increasing plant friendliness |
| * Improving selectivity/reducing impurity levels by quality chemistry inputs |
| * Reducing effluent generation |
| * Custom synthesis |
| Developing products for domestic, semi-regulated and regulated markets to be marketed through respective internal Marketing teams. |
| Custom research. |
| Innovative and novel products. |
| |
| Stage-1 Research base at Navi Mumbai : |
| Area of Focus |
| Widening DMF pipeline for regulated markets (27 DMF’s). |
| New product introductions for emerging markets. |
| Intermediate manufacturing for innovators. |
| Development of Contract Manufacturing. |
| Coverage of versatile therapeutic areas. |
| |
| Stage-2 Research Center : |
| Area of Focus |
| Development of formulations. |
| Dossier preparation and ANDA filings for regulated markets |
| Development of platforms for Novel Drug Delivery for Specialty Generics |
| Creation of facilities for clinical studies and carrying out bio-equivalence studies |
| New Product Development |
| * Development of Solid, semi-solid and liquid dosage forms. |
| * SR/ER/MR dosage forms. |
| * Off patent Generics for regulated markets (US and EU). |
| * Platform technologies (taste masking, modified release tablets, etc). |
| * Compression grade API’s (drum-to-hopper). |
| * Value added generics |
| * Other dosage forms like oral liquids, Dry Syrups, semi-solids, etc. |
| Regulatory activities |
| Intellectual Property Management |
| |
| |
| |
|
|
| |
| |
| |
| |
| R&D Addresses: |
| |
| 1.) |
|
C-415, TTC Industrial Area,
MIDC, Turbhe,
Navi Mumbai – 400 705
|
| |
| 2.) |
|
Neelkamal,
Sanghvi Estate, Govandi (E)
Mumbai – 400 088
|
|
| |
| |
